Pancreatic Cancer Research

ResearcherKobe UniversityNo recent work listed

Tadahiro Goto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5880-2968; OpenAlex author ID A5077224686. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: 1 paper

Papers 11

  1. [A Case of Pancreatic Adenocarcinoma with Inferior Vena Cava Invasion]. Co-author PMID 32389967↗
  2. Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases. First author DOI 10.1186/s40792-017-0348-5↗
  3. [A Case of Pancreatic Cancer with Multiple Lymph Node Swelling Caused by Sarcoidosis]. Co-author PMID 29394809↗
  4. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophi… Co-author DOI 10.1007/s00595-015-1206-3↗
  5. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center r… Co-author DOI 10.1016/j.pan.2015.09.008↗
  6. Postoperative Serum Albumin Level is a Marker of Incomplete Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-014-4280-7↗
  7. [A case of adjuvant surgery for a patient with initially unresectable locally advanced pancreatic cancer (LAPC) with a favorable response to S-1 chemotherapy]. Co-author PMID 25731462↗
  8. 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.cgh.2012.12.033↗
  9. [A case of metachronous pancreatic cancer that developed 4 years after initial pancreatectomy]. Co-author PMID 24393957↗
  10. [A case of interstitial lung disease associated with gemcitabine treatment in a patient with locally advanced pancreatic cancer following proton beam radiother… Co-author PMID 23268009↗
  11. A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with obstruction of the main pancreatic duct. Co-author DOI 10.1007/s11605-011-1543-5↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yonson Ku · 11 shared papers, 2011–2020 · strength 0.53
  2. Takumi Fukumoto · 10 shared papers, 2011–2017 · strength 0.42
  3. Sadaki Asari · 10 shared papers, 2011–2017 · strength 0.42
  4. Ippei Matsumoto · 8 shared papers, 2011–2016 · strength 0.30
  5. Hirochika Toyama · 5 shared papers, 2011–2016 · strength 0.19
  6. Jun Ishida · 4 shared papers, 2013–2016 · strength 0.17
  7. Sachiyo Shirakawa · 4 shared papers, 2012–2017 · strength 0.16
  8. Motofumi Tanaka · 3 shared papers, 2014–2017 · strength 0.16
  9. Takuya Mizumoto · 2 shared papers, 2017 · strength 0.12
  10. Yoshihide Nanno · 2 shared papers, 2014–2017 · strength 0.09
  11. Masaki Tanaka · 2 shared papers, 2012–2015 · strength 0.07
  12. Keitaro Sofue · 1 shared paper, 2017 · strength 0.06
  13. Mototsugu Shimokawa · 1 shared paper, 2015 · strength 0.04
  14. Yoshiaki Murakami · 1 shared paper, 2015 · strength 0.04
  15. Sohei Satoi · 1 shared paper, 2015 · strength 0.04
  16. Masanao Kurata · 1 shared paper, 2015 · strength 0.04
  17. Masayuki Sho · 1 shared paper, 2015 · strength 0.04
  18. Hiroki Yamaue · 1 shared paper, 2015 · strength 0.04
  19. Kenichiro Uemura · 1 shared paper, 2015 · strength 0.04
  20. Takahiro Akahori · 1 shared paper, 2015 · strength 0.04
  21. A‐Hon Kwon · 1 shared paper, 2015 · strength 0.04
  22. Masaji Tani · 1 shared paper, 2015 · strength 0.04
  23. Michiaki Unno · 1 shared paper, 2015 · strength 0.04
  24. Fuyuhiko Motoi · 1 shared paper, 2015 · strength 0.04
  25. Goro Honda · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.